Antimicrobial Activity of Garenoxacin (GRN), a Novel Des-F(6) Quinolone Tested Against 29,460 Community-Acquired Respiratory Pathogens (CA-RTI) from Europe, North America and Latin America
Antimicrobial Activity of Garenoxacin (GRN), a Novel Des-F(6) Quinolone Tested Against 29,460 Community-Acquired Respiratory Pathogens (CA-RTI) from Europe, North America and Latin America, Lead author: Jones RN, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal
